{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/navigating-recruitment-complexity-and-regional-nuances-phase-iii-global-geographic-atrophy#webpage",
"url": "https://www.fortrea.com/insights/navigating-recruitment-complexity-and-regional-nuances-phase-iii-global-geographic-atrophy",
"name": "Navigating recruitment complexity and regional nuances in a Phase III Global Geographic Atrophy trial",
"description": "This Fortrea case study explores the recruitment strategy behind a registrational Phase III geographic atrophy clinical trial conducted across eight countries and 50 sites in the United States, Europe, and Asia-Pacific. Although enrollment progressed as expected in Western regions, APAC recruitment lagged because geographic atrophy patients were not routinely presenting to ophthalmology clinics due to differences in regional healthcare pathways and standards of care. Recognizing that traditional site-based recruitment methods would not achieve enrollment goals, Fortrea implemented a targeted strategy that combined regional leadership engagement, collaboration with recruitment vendors, localized patient identification efforts, and sustained site support to address country-specific recruitment barriers. By adapting operational approaches to local healthcare realities and maintaining strong communication across study stakeholders, the team successfully accelerated enrollment, completed recruitment one month ahead of schedule, and randomized 530 patients compared with the original target of 500, demonstrating an effective model for managing recruitment complexity in global geographic atrophy and ophthalmology clinical trials."
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "Navigating recruitment complexity and regional nuances in a Phase III Global Geographic Atrophy trial",
"item": "https://www.fortrea.com/insights/navigating-recruitment-complexity-and-regional-nuances-phase-iii-global-geographic-atrophy"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry—as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. This commitment is further reinforced by the launch of Fortrea Intelligent Technology, enabling smarter, more connected, and data-driven clinical development. Through Fortrea Intelligent Technology, the organization is advancing data-driven, technology-enabled clinical development to improve speed, quality, and patient outcomes. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/navigating-recruitment-complexity-and-regional-nuances-phase-iii-global-geographic-atrophy#casestudy",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/navigating-recruitment-complexity-and-regional-nuances-phase-iii-global-geographic-atrophy#webpage"
},
"headline": "Phase III Geographic Atrophy Trial Recruitment: Overcoming Global Enrollment Challenges Across APAC, Europe and the U.S. | Fortrea Case Study",
"description": "This Fortrea case study explores the recruitment strategy behind a registrational Phase III geographic atrophy clinical trial conducted across eight countries and 50 sites in the United States, Europe, and Asia-Pacific. Although enrollment progressed as expected in Western regions, APAC recruitment lagged because geographic atrophy patients were not routinely presenting to ophthalmology clinics due to differences in regional healthcare pathways and standards of care. Recognizing that traditional site-based recruitment methods would not achieve enrollment goals, Fortrea implemented a targeted strategy that combined regional leadership engagement, collaboration with recruitment vendors, localized patient identification efforts, and sustained site support to address country-specific recruitment barriers. By adapting operational approaches to local healthcare realities and maintaining strong communication across study stakeholders, the team successfully accelerated enrollment, completed recruitment one month ahead of schedule, and randomized 530 patients compared with the original target of 500, demonstrating an effective model for managing recruitment complexity in global geographic atrophy and ophthalmology clinical trials.",
"genre": "Case Study",
"image": {
"@type": "ImageObject",
"url": "https://www.fortrea.com/sites/default/files/2026-02/phase-3-geographic-atrophy-trial-recruitment.jpg"
},
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2026-02-25",
"dateModified": "2026-02-25",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2026-02/phase-3-geographic-atrophy-trial-recruitment.pdf",
"encodingFormat": "application/pdf"
}
}
]
}